whether shielding of chest in premature babies under phototherapy prevents PDA

Effect of chest shielding on incidence of haemodynamically significant patent ductus arteriosus in very preterm neonates under phototherapy

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011069

Enrollment

120

Registered

2018-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- preterm neonates under phototherapy

Interventions

Intervention1: chest shielding: babies meeting the inclusion criteria will be randomised into two groups. one group will have their left side of chest shielded with food grade aluminium foil while und

Eligibility

Inclusion criteria

Inclusion criteria: Very preterm (gestation Admitted to NICU/Intermediate care nursery within 24 hours of birth

Exclusion criteria

Exclusion criteria: 1.Diagnosed to have haemodynamically significant patent ductus arteriosus before starting phototherapy 2.Major congenital malformations 3.Death within 12 hours of admission

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of chest shielding on incidence of hemodynamically significant patent ductus arteriosus in very preterm neonates under phototherapyTimepoint: Till day 7 of life or till the baby was on phototherapy for neonatal jaundice neonates under phototherapy	—

Secondary

Measure	Time frame
To evaluate the effect of chest shielding on the incidence of patent ductus arteriosus and other neonatal morbidities Timepoint: Till day 7 of life or till the baby was on phototherapy for neonatal jaundice	—

Countries

India

Contacts

Public ContactSAURABH KAPOOR

Govt. medical college and hospital, sector 32, chandigarh

sk_1471@yahoo.in9164131734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 26, 2026